Literature DB >> 14664198

Triggers for use, optimal dosing, and problems associated with red cell transfusions.

Jennifer E Prittie1.   

Abstract

The administration of RBC components can dramatically improve tissue oxygenation in small animals with symptomatic anemia and can be life saving. This therapy is not without risk, however. Careful consideration of the transfusion trigger, appropriate screening of the donor and recipient, and selection of the optimal RBC component and dose on an individual patient basis can help to limit the occurrence of adverse transfusion-related events. Appropriate component administration techniques, careful monitoring of recipients for the development of transfusion reactions, and prompt recognition and treatment of transfusion reactions are also essential in assuring safe transfusion practice.

Entities:  

Mesh:

Year:  2003        PMID: 14664198     DOI: 10.1016/s0195-5616(03)00093-7

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  4 in total

1.  In vitro lysis and acute transfusion reactions with hemolysis caused by inappropriate storage of canine red blood cell products.

Authors:  J Patterson; A Rousseau; R J Kessler; U Giger
Journal:  J Vet Intern Med       Date:  2011-05-25       Impact factor: 3.333

Review 2.  Iron deficiency anemia.

Authors:  Dinaz Z Naigamwalla; Jinelle A Webb; Urs Giger
Journal:  Can Vet J       Date:  2012-03       Impact factor: 1.008

3.  Assessment of clinical and laboratory variables as a guide to packed red blood cell transfusion of euvolemic anemic dogs.

Authors:  C Kisielewicz; I Self; R Bell
Journal:  J Vet Intern Med       Date:  2014-01-13       Impact factor: 3.333

4.  Effect of cross-match on packed cell volume after transfusion of packed red blood cells in transfusion-naïve anemic cats.

Authors:  Brittany Sylvane; Jennifer Prittie; Ann E Hohenhaus; Erik Tozier
Journal:  J Vet Intern Med       Date:  2018-03-23       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.